Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Scientific Reports|August 26, 2017
Erratum: Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophreniaSzabolcs Kéri, Csilla Szabó, Oguz KelemenOrvosi Hetilap|April 11, 2018
[Interventions in medical practice to reduce tobacco use among adolescents]Dávid Pócs, Katalin Barabás, Oguz KelemenScience Progress|January 27, 2026
AI-derived research domain criteria scores from medical records predict brain inflammatory markers in psychotic disorders: A cross-sectional, real-world studySzabolcs Kéri, Balázs Barko, Oguz KelemenPsychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|December 28, 2025
[Tailored Treatment: Opportunities for Algorithm-Based Modular Psychotherapy in Hungarian Mental Health Care]Oguz Kelemen, Adrienn Máttyássi, Szabolcs KériLife (Basel, Switzerland)|June 28, 2023
Mentalization, Oxytocin, and Cortisol in the General PopulationEdina Török, Oguz Kelemen, Szabolcs KériOrvosi Hetilap|March 3, 2006
[Therapy of mental states at high risk for psychosis: preliminary results from Hungary]Szabolcs Kéri, Oguz Kelemen, Zoltán JankaThe American Journal of Psychiatry|January 6, 2010
Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophreniaSzabolcs Kéri, Sándor Beniczky, Oguz KelemenSocial Neuroscience|August 2, 2008
Sharing secrets: oxytocin and trust in schizophreniaSzabolcs Kéri, Imre Kiss, Oguz KelemenJournal of Psychiatric Research|January 3, 2012
Hippocampal volume and the AKT signaling system in first-episode schizophreniaAndrás Szamosi, Oguz Kelemen, Szabolcs KériJournal of Affective Disorders|May 27, 2014
Blood biomarkers of depression track clinical changes during cognitive-behavioral therapySzabolcs Kéri, Csilla Szabó, Oguz KelemenPageof 8